000 01566 a2200457 4500
005 20250516140629.0
264 0 _c20131031
008 201310s 0 0 eng d
022 _a1179-1969
024 7 _a10.1007/s40266-013-0063-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLampela, Pasi
245 0 0 _aAnticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: a population-based study.
_h[electronic resource]
260 _bDrugs & aging
_cMay 2013
300 _a321-30 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aActivities of Daily Living
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAnimals
650 0 4 _aCerebral Cortex
_xmetabolism
650 0 4 _aCholinergic Antagonists
_xadverse effects
650 0 4 _aDepression
_xprevention & control
650 0 4 _aFemale
650 0 4 _aFinland
650 0 4 _aGeriatric Assessment
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMental Status Schedule
650 0 4 _aPulmonary Disease, Chronic Obstructive
_xdrug therapy
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aUrinary Bladder, Overactive
_xdrug therapy
700 1 _aLavikainen, Piia
700 1 _aGarcia-Horsman, J Arturo
700 1 _aBell, J Simon
700 1 _aHuupponen, Risto
700 1 _aHartikainen, Sirpa
773 0 _tDrugs & aging
_gvol. 30
_gno. 5
_gp. 321-30
856 4 0 _uhttps://doi.org/10.1007/s40266-013-0063-2
_zAvailable from publisher's website
999 _c22567566
_d22567566